These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9143410)
1. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture. Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410 [TBL] [Abstract][Full Text] [Related]
2. Effects of lymphokine-activated killer-cells on melanoma nodules maintained in 3-dimensional culture. Gharib M; Tamboise E; Tamboise A; Lievre N; Verola O; Beaupain R Int J Oncol; 1995 Dec; 7(6):1327-32. PubMed ID: 21552968 [TBL] [Abstract][Full Text] [Related]
3. Lymphokine-activated killer cells induce differentiation in MCF-7 breast carcinoma nodules but not in mastosis nodules maintained in three-dimensional culture. Gharib M; Mainguené C; Tamboise E; Tamboise A; Beaupain R Tumour Biol; 1994; 15(2):90-100. PubMed ID: 8184257 [TBL] [Abstract][Full Text] [Related]
4. [Effects of LAK cells activated by IL-2 on MCF-7 human breast cancer cell line maintained in organotypic culture]. Gharib M; Mainguené C; Tamboise E; Tamboise A; Lièvre N; Amouroux J; Beaupain R Bull Cancer; 1993 Aug; 80(8):659-65. PubMed ID: 8204946 [TBL] [Abstract][Full Text] [Related]
5. Secretion of mucoid material by lymphokine-activated killer cells: study by light and electron microscopy. Ginsburg H; Coleman R; Davidson S; Yahav H; Khoury C J Leukoc Biol; 1990 May; 47(5):393-408. PubMed ID: 2186162 [TBL] [Abstract][Full Text] [Related]
6. Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist. Obligate paracrine pathway of IL-1 during lymphokine-activated killer cell induction. Fujiwara T; Grimm EA J Immunol; 1992 May; 148(9):2941-6. PubMed ID: 1374105 [TBL] [Abstract][Full Text] [Related]
7. [Electron microscopic observation on the killing of human lung carcinoma cells by lymphokine-activated killer cells (LAK cells) in vitro]. Shi J Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):319-21, 22. PubMed ID: 2169980 [TBL] [Abstract][Full Text] [Related]
8. Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generation. Blay JY; Branellec D; Robinet E; Gay F; Chouaib S J Clin Lab Anal; 1990; 4(1):54-8. PubMed ID: 2313467 [TBL] [Abstract][Full Text] [Related]
9. In vitro development of lymphocytes that function as progenitors for mucus-secreting lymphokine-activated killer (LAK) cells. Ginsburg H J Leukoc Biol; 1992 Apr; 51(4):307-15. PubMed ID: 1564395 [TBL] [Abstract][Full Text] [Related]
10. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer. Wang Z; Cheng Y; Zheng R; Qin D; Liu G Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335 [TBL] [Abstract][Full Text] [Related]
11. Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes. Yoneda K; Osaki T; Yamamoto T; Ueta E Clin Exp Immunol; 1993 Aug; 93(2):229-36. PubMed ID: 8348749 [TBL] [Abstract][Full Text] [Related]
12. Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. Kwak JY; Han MK; Choi KS; Park IH; Park SY; Sohn MH; Kim UH; McGregor JR; Samlowski WE; Yim CY Cell Immunol; 2000 Aug; 203(2):84-94. PubMed ID: 11006006 [TBL] [Abstract][Full Text] [Related]
13. Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis. Basu S; Sodhi A Anticancer Drugs; 1992 Apr; 3(2):155-62. PubMed ID: 1525394 [TBL] [Abstract][Full Text] [Related]
14. In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice. Puri RK; Leland P Clin Exp Immunol; 1991 Aug; 85(2):317-25. PubMed ID: 1713814 [TBL] [Abstract][Full Text] [Related]
15. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro. Abe Y; Van Eden M; Gatanaga M; Wang FI; Brightbill HD; Granger GA; Gatanaga T Lymphokine Cytokine Res; 1993 Oct; 12(5):279-83. PubMed ID: 8260536 [TBL] [Abstract][Full Text] [Related]
16. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy. Streck RJ; Helinski EH; Ovak GM; Pauly JL J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448 [TBL] [Abstract][Full Text] [Related]
17. Generation of a small cell lung cancer variant resistant to lymphokine-activated killer (LAK) cells: association with resistance to a LAK cell-derived, cytostatic factor. Tachibana I; Watanabe M; Tanio Y; Hayashi S; Hosoe S; Saito S; Matsunashi M; Osaki T; Shigedo Y; Masuno T Cancer Res; 1992 Jun; 52(12):3310-6. PubMed ID: 1350752 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary surfactant inhibits interleukin-2-induced proliferation and the generation of lymphokine-activated killer cells. Roth MD; Pinto M; Golub SH; Shau H Am J Respir Cell Mol Biol; 1993 Dec; 9(6):652-8. PubMed ID: 8257596 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells. Grant AJ; Merchant RE; Hall RE Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cells. Atagi S; Sone S; Fukuta K; Ogura T Jpn J Cancer Res; 1992 Oct; 83(10):1088-94. PubMed ID: 1452461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]